Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramCHIEF FINANCIAL OFFICERCIK 0001835458
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Ragosa MarkCHIEF FINANCIAL OFFICER |  KNSAKiniksa Pharmaceuticals International, plcOption exercise | M | — 2,694 sh | Apr 8, 2026 traded Apr 7, 2026 | |
Ragosa MarkCHIEF FINANCIAL OFFICER |
| KNSAKiniksa Pharmaceuticals International, plc Option exercise |
| M |
| — 2,694 sh |
| Apr 8, 2026 traded Apr 7, 2026 |
| 12 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Tax withholding | F | $64K 1,303 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 2,471 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 15 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Open-market sale · 10b5-1 plan | SELL | $382K 8,731 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 6 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $109K 8,374 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 0 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $42K 2,471 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 15 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Open-market sale · 10b5-1 plan | SELL | $391K 9,114 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 0 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 8,374 sh | Feb 11, 2026 traded Feb 9, 2026 |
| 15 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Open-market sale · 10b5-1 plan | SELL | $503K 12.0K sh | Jan 9, 2026 traded Jan 8, 2026 |
| 0 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 16.2K sh | Dec 10, 2025 traded Dec 8, 2025 |
| 6 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $193K 16.2K sh | Dec 10, 2025 traded Dec 8, 2025 |
| 10 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $179K 16.2K sh | Dec 10, 2025 traded Dec 8, 2025 |
| 0 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 16.2K sh | Dec 10, 2025 traded Dec 8, 2025 |
| 7 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 10.5K sh | Dec 10, 2025 traded Dec 8, 2025 |
| 27 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Open-market sale · 10b5-1 plan | SELL | $1.78M 42.8K sh | Dec 10, 2025 traded Dec 8, 2025 |
| 2 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $113K 10.5K sh | Dec 10, 2025 traded Dec 8, 2025 |
| 0 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 19.9K sh | Nov 14, 2025 traded Nov 12, 2025 |
| 17 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $616K 19.9K sh | Nov 14, 2025 traded Nov 12, 2025 |
| 24 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Open-market sale · 10b5-1 plan | SELL | $815K 19.9K sh | Nov 14, 2025 traded Nov 12, 2025 |